PE-backed Gemini acquires ORFLO

Gemini Bioproducts, which is backed by BelHealth Investment Partners, has acquired Ketchum, Idaho-based ORFLO Technologies, a provider of cell analysis instruments. No financial terms were disclosed.

11 November 2019•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles